Oien
San Diego-based Cidara Therapeutics Inc., a biotechnology company developing novel anti-infective drugs such as immunotherapies, announced this week it appointed Jessica Oien as general counsel and secretary.
The company's prior general counsel, Matt Onaitis, resigned from his position as chief financial officer and general counsel on Aug. 17 to pursue other opportunities, according to Paul Daruwala, chief operating officer at Cida...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In




